Scalper1 News
Medical-device maker Edwards Lifesciences (EW) was up more than 6% Wednesday morning as analysts raised their estimates in the wake of a strong Q4 earnings report late Tuesday. Edwards’ profit rose 12% over the year-earlier quarter to $1.06 a share, beating analysts’ consensus by 11 cents, according to Thomson Reuters. Sales increased 15% to $618 million, $7 million more than Wall Street expected. For the year, sales rose 14% to $2.32 billion, Scalper1 News
Scalper1 News